Literature DB >> 21948240

Pharmacokinetics of natural borneol after oral administration in mice brain and its effect on excitation ratio.

Wei-rong Li1, Rui-yu Chen, Lei Yang, Tian-lai Huang, Qing-wen Xu, Sui-qing Mi, Ning-sheng Wang.   

Abstract

Previous studies have indicated that borneol has double side effects on the central nervous system (CNS), but the mechanism is unknown. The aim of this study was to clarify the relationship between excitation ratio [contents of excitatory amino acids (AAs) versus that of inhibitory] and the content of natural borneol after a single oral dose. Mice were administered a 1.2 g/kg dose of natural borneol (containing 98% D: -borneol) by oral ingestion. Brain samples were collected before administration and at 0.083, 0.167, 0.25, 0.333, 0.5, 0.75, 1, 1.5, 2, 2.5, 3, 4 and 5 h after administration. The brain concentration of natural borneol and contents of AA neurotransmitters in mice brain were determined by GC-MS and HPLC-FLU, respectively. After per oral application, natural borneol was absorbed rapidly into the brain and could be determined 5 min after dosing. The maximal brain concentration (86.52 μg/g) was reached after 1 h post-dosing. Natural borneol could affect the contents of AA neurotransmitters in mice brain: L: -aspartic acid increased significantly from 0.083 to 1 h after administration, L: -glutamic acid increased significantly at 0.333 h and decreased from 1.5 to 5 h, gamma-amino-N-butyric acid increased significantly from 0.167 to 5 h, whereas glycine was not affected. The excitation ratio is the contents of excitatory AAs versus that of inhibitory AAs, which reflects the excitatory or inhibitory state of the body. The excitation ratio elevated transitorily and then declined 0.5 h post-dosing; there were significant differences between 1.5-5 h post-dose compared with pre-dose. The present study indicated that natural borneol could affect the contents of AA neurotransmitters, and the change in excitatory ratio led to borneol's double side effects on the CNS.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21948240     DOI: 10.1007/s13318-011-0058-5

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  4 in total

1.  The enhancing effect of synthetical borneol on the absorption of tetramethylpyrazine phosphate in mouse.

Authors:  Xiao Yan-Yu; Ping Qi-Neng; Chen Zhi-Peng
Journal:  Int J Pharm       Date:  2006-12-28       Impact factor: 5.875

2.  Common herbs, essential oils, and monoterpenes potently modulate bone metabolism.

Authors:  R C Mühlbauer; A Lozano; S Palacio; A Reinli; R Felix
Journal:  Bone       Date:  2003-04       Impact factor: 4.398

3.  Inhibition of acetylcholine-mediated effects by borneol.

Authors:  Tae-Ju Park; Yong-Soo Park; Tae-Gyun Lee; Hyunjung Ha; Kyong-Tai Kim
Journal:  Biochem Pharmacol       Date:  2003-01-01       Impact factor: 5.858

4.  (+)- And (-)-borneol: efficacious positive modulators of GABA action at human recombinant alpha1beta2gamma2L GABA(A) receptors.

Authors:  Renee E Granger; Erica L Campbell; Graham A R Johnston
Journal:  Biochem Pharmacol       Date:  2005-04-01       Impact factor: 5.858

  4 in total
  10 in total

1.  Effect of natural borneol on the pharmacokinetics and distribution of nimodipine in mice.

Authors:  Chun Wu; Qiongfeng Liao; Meicun Yao; Xinjun Xu; Yuting Zhou; Xueying Hou; Zhiyong Xie
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2013-05-15       Impact factor: 2.441

2.  Comparative pharmacokinetic studies of borneol in mouse plasma and brain by different administrations.

Authors:  Jing-yi Zhao; Yang Lu; Shou-ying Du; Xiao Song; Jie Bai; Yue Wang
Journal:  J Zhejiang Univ Sci B       Date:  2012-12       Impact factor: 3.066

3.  Borneol, a novel agent that improves central nervous system drug delivery by enhancing blood-brain barrier permeability.

Authors:  Qun-Lin Zhang; Bingmei M Fu; Zhang-Jin Zhang
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

4.  Simultaneous determination of borneol and its metabolite in rat plasma by GC-MS and its application to pharmacokinetic study.

Authors:  Xiu-Man Sun; Qiong-Feng Liao; Yu-Ting Zhou; Xue-Jiao Deng; Zhi-Yong Xie
Journal:  J Pharm Anal       Date:  2014-02-15

Review 5.  Towards Improvements for Penetrating the Blood-Brain Barrier-Recent Progress from a Material and Pharmaceutical Perspective.

Authors:  Quanguo He; Jun Liu; Jing Liang; Xiaopeng Liu; Wen Li; Zhi Liu; Ziyu Ding; Du Tuo
Journal:  Cells       Date:  2018-03-23       Impact factor: 6.600

6.  Enhanced extraction efficiency of natural D-borneol from Mei Pian tree leaves pretreated with deep eutectic solvents.

Authors:  Minghui Fu; Ziqing Lu; Xiaoyu Ma
Journal:  Food Sci Nutr       Date:  2020-06-02       Impact factor: 2.863

7.  Neuropsychopharmacological profiling of scoparone in mice.

Authors:  Joanna Kowalczyk; Barbara Budzyńska; Łukasz Kurach; Daniele Pellegata; Nesrine S El Sayed; Jürg Gertsch; Krystyna Skalicka-Woźniak
Journal:  Sci Rep       Date:  2022-01-17       Impact factor: 4.379

Review 8.  Potential clinical applications of phytopharmaceuticals for the in-patient management of coagulopathies in COVID-19.

Authors:  Ashis K Mukherjee; Dhruba J Chattopadhyay
Journal:  Phytother Res       Date:  2022-02-11       Impact factor: 6.388

9.  Borneol, a messenger agent, improves central nervous system drug delivery through enhancing blood-brain barrier permeability: a preclinical systematic review and meta-analysis.

Authors:  Qun Zheng; Zi-Xian Chen; Meng-Bei Xu; Xiao-Li Zhou; Yue-Yue Huang; Guo-Qing Zheng; Yan Wang
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419

10.  Optimization of the Preparation Conditions of Borneol-Modified Ginkgolide Liposomes by Response Surface Methodology and Study of Their Blood Brain Barrier Permeability.

Authors:  Zhiyang Lv; Yuwei Yang; Jie Wang; Jing Chen; Junsong Li; Liuqing Di
Journal:  Molecules       Date:  2018-01-31       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.